Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Zinc for Idiopathic Oligoasthenoteratozoospermia
NCT05156684Unknown
- Sponsor
- Arak University of Medical Sciences
- Start
- Jan 2022
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of pentoxifylline and zinc in idiopathic oligoasthenoteratozoospermia (iOAT) (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Count of sperm at 1 week, Motility of sperm at 1 week and 10 more. Status: unknown.
02
Drugs
pentoxifyllinezinc
03
Conditions
idiopathic oligoasthenoteratozoospermia (iOAT)
Beyond the preview
Go deeper on NCT05156684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05156684.